Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BioInvent International AB

+ Add to Watchlist

BINV:SS

2.1300 SEK 0.0100 0.47%

As of 05:49:56 ET on 05/22/2015.

Snapshot for BioInvent International AB (BINV)

Open: 2.1100 Day's Range: 2.1000 - 2.1400 Volume: 104,572
Previous Close: 2.1200 52wk Range: 1.7163 - 3.0262 1-Yr Rtn: -21.40%

Stock Chart for BINV

No chart data available.
  • BINV:SS 2.1100
  • 1D
  • 1M
  • 1Y
2.1200
Interactive BINV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BINV

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -0.4426
Est. EPS (SEK) (12/2015) -0.1740
Est. PEG Ratio -
Market Cap (M SEK) 344.01
Shares Outstanding (M) 112.79
30 Day Average Volume 368,240
Price/Book (mrq) 8.6657
Price/Sale (ttm) 5.0489
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/22/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BINV

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for BINV

BioInvent International AB is a research and development company within biotechnology. The Company has created human antibody libraries that can be used in a broad range of applications. BioInvent delivers proteins to drug and biotechnology companies, grants licenses for use of its libraries, and establishes partnerships to develop and manufacture protein based drugs.

Michael S OredssonPresident/CEOPer-Anders JohanssonSenior VP:Tech Operations
Martin WilesSenior VP:Business DevelopmentBjoern FrendeusVP:Preclinical Research
More Company Profile & Key Executives for BINV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil